Compound Detail
CHEMBL427216
GLICLAZIDE 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL427216 |
| Name | GLICLAZIDE |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | BOVGTQGAOIONJV-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
2
Targets
4
Activities
1
Assay Types
0
PK Parameters
20
Publications
22
Known Names
3
Indications
1
Mechanisms
Molecular Properties
323.4
MW (Da)
1.63
ALogP
4
HBA
2
HBD
78.5
PSA (Ų)
0.89
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Sulfonylurea receptor 1, Kir6.2 blocker | BLOCKER | Sulfonylurea receptor 1, Kir6.2 | ✓ | ✓ |
Indications
Diabetes Mellitus Diabetes Mellitus, Type 2 Epilepsy
ATC Classification
A10BB09
gliclazide
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: DRUGS USED IN DIABETES
Activity Summary
IC50 4 meas. best 6.19
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 6.19 | 5.965 | 640.3 | 2 |
| Aldo-keto reductase family 1 member C3 CHEMBL4681 | IC50 | 4.71 | 4.71 | 19620.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 640.33 | nM | 6.19 | PubChem BioAssay. tonic K+ channel activity under 0.1 mM glucose conditions in I... | - |
| Unchecked | IC50 | = | 1833.95 | nM | 5.74 | PubChem BioAssay. insulin secretion from INS-1E cells in the presence of 5 mM gl... | - |
| Aldo-keto reductase family 1 member C3 | IC50 | = | 19620.0 | nM | 4.71 | Inhibition of N-terminal His-tagged human AKR1C3 expressed in Escherichia coli B... | 32463235 |
Literature References
Data from ChEMBL 36 via Core Engine